Nabi Seeking StaphVax Indication For All At-Risk Groups; BLA Filing Planned By End Of 2005

Company announces initiation of Phase IIb immunogenicity trials for prevention of S. aureus infection in cardiovascular and orthopedic surgery patients July 22. Trials will complement ongoing confirmatory Phase III trial in end-stage renal disease patients.